Revolution Medicines (RVMD) Current Deferred Revenue (2019 - 2023)
Revolution Medicines' Current Deferred Revenue was $1.43 million in Q1 2023, down 87.5% from $11.43 million a year earlier and down 67.8% from the prior quarter.
Powered by 
Analysis
Revolution Medicines (RVMD) Current Deferred Revenue (2019 - 2023) Analysis & Trends
At the end of FY2022, Current Deferred Revenue at Revolution Medicines came in at $4.46 million, down 63.9% from FY2021.
- Current Deferred Revenue shows a three-year compound annual growth rate of -36.1% (FY2019 to FY2022).
- In earlier years, Current Deferred Revenue was $12.36 million in FY2021 (+2.0%), $12.11 million in FY2020 (-29.3%) and $17.12 million in FY2019.
- The Q1 2023 figure marks the lowest quarterly Current Deferred Revenue in data going back to Q4 2019.
- Compared with a year earlier, Current Deferred Revenue has declined for three straight quarters, with an average decline of 23.5% over the last eight quarters.
- The best year-over-year quarter for Current Deferred Revenue over five years was Q2 2022 (growth of 16.2%); the worst was Q1 2023 (a decline of 87.5%).
- Per Business Quant data, RVMD's Current Deferred Revenue in the three quarters before Q1 2023 was $4.46 million (Q4 2022), $9.69 million (Q3 2022) and $9.69 million (Q2 2022).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,221.09 Bn | 1,194.71 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 656.38 Bn | 576.24 Bn | 17.30 Bn |
| 3 | AbbVie | 510.79 Bn | 478.80 Bn | 13.12 Bn |
| 4 | Merck | 363.00 Bn | 317.38 Bn | 12.21 Bn |
| 5 | Novartis Ag | 313.89 Bn | 287.12 Bn | - |
| 6 | Astrazeneca | 290.02 Bn | 263.91 Bn | 13.26 Bn |
| 7 | Amgen | 249.59 Bn | 204.98 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 208.15 Bn | 183.26 Bn | 6.73 Bn |
| 9 | Pfizer | 170.74 Bn | 118.10 Bn | 12.56 Bn |
| 10 | Revolution Medicines | 38.00 Bn | 28.20 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2023 | 1.43 Mn |
| Dec 31, 2022 | 4.46 Mn |
| Sep 30, 2022 | 9.69 Mn |
| Jun 30, 2022 | 9.69 Mn |
| Mar 31, 2022 | 11.43 Mn |
| Dec 31, 2021 | 12.36 Mn |
| Sep 30, 2021 | 12.67 Mn |
| Jun 30, 2021 | 8.34 Mn |
| Mar 31, 2021 | 9.96 Mn |
| Dec 31, 2020 | 12.11 Mn |
| Sep 30, 2020 | 13.11 Mn |
| Jun 30, 2020 | 14.58 Mn |
| Mar 31, 2020 | 16.40 Mn |
| Dec 31, 2019 | 17.12 Mn |
API Access
Revolution Medicines Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=RVMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "RVMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=RVMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();